A pH-responsive mesoporous silica nanoparticle-based drug delivery system for targeted breast cancer therapy
Jie Chang, Liufang Mo, Jinfeng Song, Xiaochen Wang, Hanhan Liu, Chenchen Meng, Yijun Wu
Abstract
anti-tumor experiments and hemolytic experiments indicated that DMPA can accurately target breast cancer cells and show excellent safety at the same time, showing great potential for tumor therapy.
Topics & Concepts
Mesoporous silicaEndocytosisDoxorubicinDrug deliveryNanoparticleIn vivoMesoporous materialMaterials scienceCancer cellPaclitaxelDrug carrierBiophysicsEndosomeNanotechnologyChemistryCancerBiochemistryChemotherapyReceptorMedicineBiologyCatalysisInternal medicineSurgeryBiotechnologyNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsCancer Treatment and Pharmacology